compounded semaglutide lawsuit Makers of Wegovy, Ozempic threatened by FDA move Lilly seeks to intervene in
Description
Over the two-year study period, patients receiving GLP-1based therapy experienced: Importantly, the study authors did not observe an increased risk for key diabetes-related complications, including diabetic ketoacidosis and hypoglycemia
doi: 10.1159/000494235
It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency [3]
What happens next is anyone's guess, says Brunner
